Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
22882 | 365 | 25.9 | 58% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
11 | 3 | ATRIAL FIBRILLATION//CARDIAC & CARDIOVASCULAR SYSTEM//CATHETER ABLATION | 130936 |
822 | 2 | CALCIUM ANTAGONISTS//CALCIUM CHANNEL BLOCKERS//NIFEDIPINE | 11902 |
22882 | 1 | BEPRIDIL//CAS 117241 46 0//REVUE DE MEDECINE | 365 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | BEPRIDIL | authKW | 2014705 | 14% | 47% | 51 |
2 | CAS 117241 46 0 | authKW | 250973 | 1% | 100% | 3 |
3 | REVUE DE MEDECINE | journal | 167867 | 5% | 12% | 17 |
4 | 3 4 ALLYL 1 PIPERAZINYL 2 2 DIMETHYLPROPYL METHYL 1 4 DIHYDRO 2 6 DIMETHYL 4 3 NITROPHENYL 3 5 PYRIDINEDICARB | authKW | 167316 | 1% | 100% | 2 |
5 | MUSCARINIC ACETYLCHOLINE RECEPTOR OPERATED POTASSIUM CURRENT | authKW | 167316 | 1% | 100% | 2 |
6 | NKY 722 PHARMACOLOGY | authKW | 167316 | 1% | 100% | 2 |
7 | NKY 722 | authKW | 150582 | 1% | 60% | 3 |
8 | 3 4 ALLYL 1 PIPERAZINYL 2 2 DIMETHYLPROPYLMETHYL 1 4 DIHYDRO 2 6 DIMETHYL 4 3 NITROPHENYL 3 5 PYRIDINEDICARBO | authKW | 83658 | 0% | 100% | 1 |
9 | ANTI ELECTRICAL REMODELLING | authKW | 83658 | 0% | 100% | 1 |
10 | ANTIARRHYTHMIC DRUGS INVIVO | authKW | 83658 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cardiac & Cardiovascular System | 4142 | 42% | 0% | 153 |
2 | Pharmacology & Pharmacy | 2989 | 53% | 0% | 192 |
3 | Peripheral Vascular Diseases | 191 | 7% | 0% | 27 |
4 | Chemistry, Medicinal | 55 | 4% | 0% | 16 |
5 | Medicine, General & Internal | 46 | 7% | 0% | 25 |
6 | Toxicology | 11 | 2% | 0% | 9 |
7 | Chemistry, Multidisciplinary | 2 | 5% | 0% | 18 |
8 | Physiology | 1 | 2% | 0% | 6 |
9 | Medicine, Research & Experimental | 0 | 2% | 0% | 6 |
10 | Engineering, Biomedical | 0 | 1% | 0% | 3 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOPHYS 27 BD J MOULIN | 83658 | 0% | 100% | 1 |
2 | INTELLIGENT CLIN INNOVAT | 83658 | 0% | 100% | 1 |
3 | NIHON UNIV MEDCHIYODA KU | 83658 | 0% | 100% | 1 |
4 | PRECLIN DEV 1 | 83658 | 0% | 100% | 1 |
5 | CARDIOLBUNKYO KU | 27885 | 0% | 33% | 1 |
6 | PHARMACOL CHINESE MATERIA MED | 13941 | 0% | 17% | 1 |
7 | REGENERAT MED THER EUT GENET MED RE | 13941 | 0% | 17% | 1 |
8 | CARDIOANGIOL | 11632 | 1% | 3% | 4 |
9 | SURG ANESTHESIOL CRIT CARE MED | 9294 | 0% | 11% | 1 |
10 | MED DENS PHARMACEUT SCI | 7603 | 0% | 9% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | REVUE DE MEDECINE | 167867 | 5% | 12% | 17 |
2 | AMERICAN JOURNAL OF CARDIOLOGY | 6084 | 12% | 0% | 44 |
3 | ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE | 5321 | 3% | 1% | 12 |
4 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 5125 | 7% | 0% | 26 |
5 | CIRCULATION JOURNAL | 4641 | 4% | 0% | 16 |
6 | ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE | 3669 | 2% | 1% | 8 |
7 | EUROPEAN JOURNAL OF PHARMACOLOGY | 2147 | 7% | 0% | 27 |
8 | THERAPIE | 2096 | 2% | 0% | 8 |
9 | LYON MEDICAL | 1222 | 1% | 1% | 2 |
10 | ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX | 1060 | 2% | 0% | 9 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HOLLINGSHEAD, LM , FAULDS, D , FITTON, A , (1992) BEPRIDIL - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN STABLE ANGINA-PECTORIS.DRUGS. VOL. 44. ISSUE 5. P. 835-857 | 89 | 85% | 35 |
2 | GILL, A , FLAIM, SF , DAMIANO, BP , SIT, SP , BRANNAN, MD , (1992) PHARMACOLOGY OF BEPRIDIL.AMERICAN JOURNAL OF CARDIOLOGY. VOL. 69. ISSUE 11. P. D11-D16 | 28 | 90% | 38 |
3 | ISHIZAKA, T , TAKAHARA, A , IWASAKI, H , MITSUMORI, Y , KISE, H , NAKAMURA, Y , SUGIYAMA, A , (2008) COMPARISON OF ELECTROPHARMACOLOGICAL EFFECTS OF BEPRIDIL AND SOTALOL IN HALOTHANE-ANESTHETIZED DOGS.CIRCULATION JOURNAL. VOL. 72. ISSUE 6. P. 1003 -1011 | 23 | 52% | 6 |
4 | SINGH, BN , (1992) SAFETY PROFILE OF BEPRIDIL DETERMINED FROM CLINICAL-TRIALS IN CHRONIC STABLE ANGINA IN THE UNITED-STATES.AMERICAN JOURNAL OF CARDIOLOGY. VOL. 69. ISSUE 11. P. D68-D74 | 21 | 95% | 20 |
5 | KANG, L , ZHENG, MQ , MORISHIMA, M , WANG, Y , KAKU, T , ONO, K , (2009) BEPRIDIL UP-REGULATES CARDIAC NA+ CHANNELS AS A LONG-TERM EFFECT BY BLUNTING PROTEASOME SIGNALS THROUGH INHIBITION OF CALMODULIN ACTIVITY.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 157. ISSUE 3. P. 404 -414 | 21 | 53% | 15 |
6 | AOYAMA, Y , NIWANO, S , NIWANO, H , SATOH, A , KISHIHARA, J , ISHIKAWA, S , MURAKAMI, M , FUKUMOTO, K , UENO, K , IZUMI, T , (2011) REPETITIVE EVALUATION OF FIBRILLATION CYCLE LENGTH PREDICTS THE EFFICACY OF BEPRIDIL FOR INTERRUPTION OF LONG-LASTING PERSISTENT ATRIAL FIBRILLATION.INTERNATIONAL HEART JOURNAL. VOL. 52. ISSUE 6. P. 353-358 | 16 | 67% | 3 |
7 | ZELLER, FP , SPINLER, SA , (1987) BEPRIDIL - A NEW LONG-ACTING CALCIUM-CHANNEL BLOCKING-AGENT.DRUG INTELLIGENCE & CLINICAL PHARMACY. VOL. 21. ISSUE 6. P. 487-492 | 27 | 90% | 4 |
8 | SUZUKI, S , KURATA, Y , LI, PL , NOTSU, T , HASEGAWA, A , IKEDA, N , KATO, M , MIAKE, J , SAKATA, S , SHIOTA, G , ET AL (2012) STABILIZATION OF KV1.5 CHANNEL PROTEIN BY BEPRIDIL THROUGH ITS ACTION AS A CHEMICAL CHAPERONE.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 696. ISSUE 1-3. P. 28 -34 | 18 | 55% | 2 |
9 | SHIGA, T , HASHIGUCHI, M , NAGANUMA, M , SUZUKI, A , HAGIWARA, N , (2013) CONTRIBUTING FACTORS TO THE APPARENT CLEARANCE OF BEPRIDIL IN PATIENTS WITH PAROXYSMAL OR PERSISTENT ATRIAL FIBRILLATION: ANALYSIS USING POPULATION PHARMACOKINETICS.THERAPEUTIC DRUG MONITORING. VOL. 35. ISSUE 3. P. 367 -373 | 13 | 72% | 0 |
10 | FLAIM, SF , CUMMINGS, DM , (1986) BEPRIDIL HYDROCHLORIDE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES.CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL. VOL. 39. ISSUE 4. P. 568-597 | 34 | 71% | 7 |
Classes with closest relation at Level 1 |